KO

KOREAN DRUG CO., LTD.

Develops, manufactures, and markets pharmaceuticals and other healthcare products.

014570 | KO

Overview

Corporate Details

ISIN(s):
KR7014570006
LEI:
Country:
South Korea
Address:
경기도 이천시 신둔면 원적로 69-10, 이천시

Description

Korean Drug Co., Ltd. is a pharmaceutical company engaged in the development, manufacturing, and marketing of a diverse range of healthcare products. The company's portfolio includes over-the-counter (OTC) and prescription (ETC) medicines, health supplements, cosmetics, and medical devices. It aims to provide comprehensive health solutions. The company is also active in research and development, maintaining a drug pipeline and conducting clinical trials in various therapeutic areas, including treatments for the nervous system.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-13 00:00
자기주식처분결과보고서
Korean 16.2 KB
2025-08-11 00:00
주요사항보고서(자기주식처분결정)
Korean 28.5 KB
2025-07-02 00:00
자기주식처분결과보고서
Korean 16.3 KB
2025-06-30 00:00
주요사항보고서(자기주식처분결정)
Korean 28.6 KB
2025-06-05 00:00
자기주식처분결과보고서
Korean 16.3 KB
2025-06-02 00:00
주요사항보고서(자기주식처분결정)
Korean 28.6 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1019.2 KB
2025-03-21 00:00
정기주주총회결과
Korean 23.7 KB
2025-03-21 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 12.6 KB
2025-03-13 00:00
감사보고서제출
Korean 18.4 KB
2025-03-13 00:00
사업보고서 (2024.12)
Korean 444.5 KB
2025-03-06 00:00
자기주식처분결과보고서
Korean 16.3 KB
2025-03-04 00:00
주요사항보고서(자기주식처분결정)
Korean 28.5 KB
2025-02-26 00:00
주주총회소집공고
Korean 102.6 KB

Automate Your Workflow. Get a real-time feed of all KOREAN DRUG CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOREAN DRUG CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOREAN DRUG CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.